Explore
Trendline
Lunai Bioworks Secures $20 Million to Enhance CNS Drug Delivery and Neurotherapeutics
Lunai Bioworks Secures $20 Million to Enhance CNS Drug Delivery and Neurotherapeutics
Read More
Trendline
Seer Appoints Anthony Bazarko as Chief Commercial Officer to Drive Growth
Seer Appoints Anthony Bazarko as Chief Commercial Officer to Drive Growth
Read More
Trendline
ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates
ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates
Read More
Trendline
Summit Shares Plummet as PD-1/VEGF Drug Fails Early Survival Benchmark
Summit Shares Plummet as PD-1/VEGF Drug Fails Early Survival Benchmark
Read More
Trendline
Twist Bioscience Reports Fiscal 2026 Q2 Financial Results Highlighting Growth
Twist Bioscience Reports Fiscal 2026 Q2 Financial Results Highlighting Growth
Read More
Trendline
Rosen Law Firm Urges Atara Biotherapeutics Investors to Act Before Class Action Deadline
Rosen Law Firm Urges Atara Biotherapeutics Investors to Act Before Class Action Deadline
Read More
AP News
Wall Street pulls back and oil prices jump as tensions rise in the war with Iran
U.S. stocks are pulling back from their record heights, while oil prices jump with uncertainty about when oil tankers can resume crossing the Strait of Hormuz and restore the world’s flow of crude
Read More
AP News
Wall Street hesitates and oil prices climb with uncertainty about the Strait of Hormuz
U.S. stocks are holding tentatively near their record heights, while oil prices climb with uncertainty about when oil tankers can resume crossing the Strait of Hormuz and restore the world’s flow of crude
Read More
Trendline
Cerebras Aims for $3.5 Billion in IPO Amid AI Market Surge
Cerebras Aims for $3.5 Billion in IPO Amid AI Market Surge
Read More
Trendline
Acadia Pharmaceuticals Announces Retirement of R Head Elizabeth H.Z. Thompson, Ensuring Continuity in Alzheimer's Research
Acadia Pharmaceuticals Announces Retirement of R Head Elizabeth H.Z. Thompson, Ensuring Continuity in Alzheimer's Research
Read More
Trendline
Merck Ends Development of TROP ADC Amidst Strategic Pipeline Adjustments
Merck Ends Development of TROP ADC Amidst Strategic Pipeline Adjustments
Read More
Trendline
Chip Stocks Experience Historic Surge as AI Concerns Diminish
Chip Stocks Experience Historic Surge as AI Concerns Diminish
Read More